MedTrace Logo

Long-term Outcome of End-stage Renal Disease Patients Treated With Hig-efficiency Hemodiafiltration

NCT02576873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2016-07-28

No results posted yet for this study

Summary

A retrospective cohort study was conducted in 66 end-stage renal disease patients who underwent high-efficiency hemodiafiltration technique in King Chulalongkorn Memorial Hospital between 2001-2013 to determine the survival rate as well as other long-term outcome.

Conditions

  • End-stage Renal Disease

Interventions

OTHER

Hemodiafiltration

Hemodiafiltration treatments were prescribed to the patients as their long-term renal replacement therapies

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Khajohn Tiranathanagul, MD · Chulalongkorn University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-10-31
Completion
2016-03-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576873 on ClinicalTrials.gov